Amryt Pharma (Amryt Pharma) Days Payable : 355.84 (As of Sep. 2022)

View and export this data going back to 2019. Start your Free Trial

What is Amryt Pharma Days Payable?

Amryt Pharma's average Accounts Payable for the three months ended in Sep. 2022 was $131.4 Mil. Amryt Pharma's Cost of Goods Sold for the three months ended in Sep. 2022 was $33.7 Mil. Hence, Amryt Pharma's Days Payable for the three months ended in Sep. 2022 was 355.84.

The historical rank and industry rank for Amryt Pharma's Days Payable or its related term are showing as below:

AMYT' s Days Payable Range Over the Past 10 Years
Min: 70.66 Med: 173.9 Max: 671.34
Current: 324.68

During the past 12 years, Amryt Pharma's highest Days Payable was 671.34. The lowest was 70.66. And the median was 173.90.

AMYT's Days Payable is not ranked
in the Drug Manufacturers industry.
Industry Median: 87.73 vs AMYT: 324.68

Amryt Pharma's Days Payable declined from Sep. 2021 (366.79) to Sep. 2022 (355.84). It may suggest that Amryt Pharma accelerated paying its suppliers.

Amryt Pharma Days Payable Historical Data

The historical data trend for Amryt Pharma's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amryt Pharma Days Payable Chart

Amryt Pharma Annual Data

Trend

Mar12

Mar13

Mar14

Mar15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Days Payable

Get a 7-Day Free Trial

216.67

319.65

131.12

70.66

111.19

Amryt Pharma Quarterly Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Days Payable	Get a 7-Day Free Trial															366.79	258.52	263.61	361.92	355.84

Competitive Comparison of Amryt Pharma's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, Amryt Pharma's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Amryt Pharma's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Amryt Pharma's Days Payable distribution charts can be found below:

* The bar in red indicates where Amryt Pharma's Days Payable falls into.

Amryt Pharma Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Amryt Pharma's Days Payable for the fiscal year that ended in Dec. 2021 is calculated as

	Days Payable (A: Dec. 2021 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2020 )	+	Accounts Payable (A: Dec. 2021 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2021 )	*	Days in Period
=	( (23.595	+	41.057)	/	2 )	/	106.119	*	365
=	32.326					/	106.119	*	365
=	111.19

Amryt Pharma's Days Payable for the quarter that ended in Sep. 2022 is calculated as:

	Days Payable (Q: Sep. 2022 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2022 )	+	Accounts Payable (Q: Sep. 2022 ))	/	count )	/	Cost of Goods Sold (Q: Sep. 2022 )	*	Days in Period
=	( (127.909	+	134.947)	/	2 )	/	33.703	*	365 / 4
=	131.428					/	33.703	*	365 / 4
=	355.84

Amryt Pharma Days Payable Related Terms

Thank you for viewing the detailed overview of Amryt Pharma's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Amryt Pharma (Amryt Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amryt Pharma PLC (NAS:AMYT) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

196 High Road, Dept 920A, Wood Green, London, GBR, N22 8HH

Website

http://www.amrytpharma.com

Amryt Pharma PLC is a specialty pharmaceutical company. It is focused on developing and delivering new treatments to help improve the lives of patients with rare or orphan diseases. It holds an exclusive license to sell Lojuxta (lomitapide) for adults, across the European Union and other territories including the Middle East, North Africa, Turkey and Israel. Lojuxta is used to treat a rare life-threatening disease called Homozygous Familial Hypercholesterolemia. Myalept (metreleptin) is an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients. It derives most of the revenue from the European Economic Area (EEA).